Advent Venture backs MetaPhore
The UK IT and life sciences investor has made its third investment in as many weeks as part of a $30m investment in the US pharmaceuticals firm.
30 December 2012•2 mins read
The UK IT and life sciences investor has made its third investment in as many weeks as part of a $30m investment in the US pharmaceuticals firm.
Bridgepoint taps former RAF chief in €1bn defense strategy launch
23 hours ago · 4 mins read
Stacking up: How PE performs in each region
10 November 2026 · 2 mins read
Side Letter: Exits and earnings
9 November 2026 · 3 mins read
Private Take: Reading beyond the scoreboard
9 November 2026 · 4 mins read
PEI Private Equity Awards 2026: Send us your highlights!
5 November 2026 · 6 mins read
Side Letter: Markdowns, moratoriums
5 November 2026 · 2 mins read
AllianzGI leaves door open for reversal of PE pullback
5 November 2026 · 2 mins read
